marijuana stocks news

Form 8-K for DEWMAR INTERNATIONAL BMC, INC.


4-Feb-2015

Change in Directors or Principal Officers, Other Events

ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.As announced on May 7, 2013, in accordance with company by-laws, the Nominating Committee of the Board had commenced an exhaustive search for a director who would qualify to serve in the vacated seat of the late Kevin Murphy.

The search has been successfully concluded and today Dewmar International announced that its Board of Directors has appointed Jacob Houston to serve as a director on the company’s Board. Additionally, Mr. Houston has been named President and Chief Operating Officer of the Company. Mr. Houston, age 44, was selected for a seat on the Board of Directors because of his demonstrative ability to help accelerated growth companies reach critical mass. Mr. Houston has extensive experience in many aspects of business including finance, sales and marketing.

 

ITEM 8.01 Other EventsTotal number of Authorized Shares for the Company is 4,500,000,000

February 3, 2015:   Issued & Outstanding Shares 2,476,163,513 Float  2,225,613,590

September 30, 2014: Issued & Outstanding Shares 2,446,163,513 Float: 2,225,613,590

June 30, 2014:      Issued & Outstanding Shares 2,446,163,513 Float: 2,225,613,590

March 31, 2014:     Issued & Outstanding Shares 2,414,913,513 Float: 2,225,613,590

February 28, 2014:  Issued & Outstanding Shares 2,351,513,513 Float: 2,145,565,972

January 1, 2014:    Issued & Outstanding Shares 2,003,998,796 Float: 1,771,051,255


 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Aurora Cannabis Inc. (ACB) CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors

Aurora CEO Miguel Martin takes on additional role as Executive Chairman of…

Cara Therapeutics, Inc. (CARA) Announces Initiation of Phase 2 Trial of Oral KORSUVA™

Cara Therapeutics Announces Initiation of Phase 2 Trial of Oral KORSUVA™ (CR845/difelikefalin)…

$ATTBF New Corporate Communications Appointment

Abattis Announces New Corporate Communications Appointment Vancouver, BC / ACCESSWIRE / February…

22nd Century Group, Inc. (XXII) Appoints New Director and New Chairman

22nd Century Group Appoints New Director and New Chairman 22nd Century Group,…